Similar articles for PMID: 23647127

Year	Number of Results
1960	1
1977	1
1978	1
1983	1
1988	1
1989	1
1995	1
1996	3
1997	2
1998	1
1999	3
2000	5
2001	1
2002	3
2003	2
2005	2
2006	4
2007	3
2008	2
2009	6
2010	3
2011	1
2012	1
2013	5
2014	1
2015	2
2016	2
2020	1
2021	3
2022	1
2024	0

1

Analysis of saliva samples from oncological patients treated with 5-fluorouracil and leucovorin calcium by scanning electron microscopy with energy dispersive system.

Mazzeo MA, Linares JA, López MM, Bachmeier E, Wietz FM, Galván V, Valentinuzzi MC, Riveros JA, Finkelberg A. Mazzeo MA, et al. J Oral Pathol Med. 2013 Nov;42(10):788-92. doi: 10.1111/jop.12078. Epub 2013 May 6. J Oral Pathol Med. 2013. PMID: 23647127

2

Oral signs of intravenous chemotherapy with 5-Fluorouracil and Leucovorin calcium in colon cancer treatment.

Mazzeo MA, Linares JA, Campos ML, Busamia BE, Dubersarsky C, Lavarda M, Jarchum G, Finkelberg AB. Mazzeo MA, et al. Med Oral Patol Oral Cir Bucal. 2009 Mar 1;14(3):E108-13. Med Oral Patol Oral Cir Bucal. 2009. PMID: 19242388 Free article.

3

Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).

Baumgaertner I, Quinaux E, Khalil A, Louvet C, Buyse M, de Gramont A, André T; GERCOR Group. Baumgaertner I, et al. Clin Colorectal Cancer. 2010 Apr;9(2):E5-10. doi: 10.3816/CCC.2010.n.027. Clin Colorectal Cancer. 2010. PMID: 20378497 Clinical Trial.

4

Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.

Costantini CL, Reid TR, Bouvet M. Costantini CL, et al. Hepatogastroenterology. 2009 May-Jun;56(91-92):645-9. Hepatogastroenterology. 2009. PMID: 19621672

5

[Treatment of rectal cancer and follow up].

Charúa-Guindic L. Charúa-Guindic L. Rev Gastroenterol Mex. 2007 Nov;72 Suppl 2:126-31. Rev Gastroenterol Mex. 2007. PMID: 18277500 Spanish. No abstract available.

6

UFT/leucovorin vs 5-FU/leucovorin in colon cancer.

Smith RE, Lembersky BC, Wieand HS, Colangelo L, Mamounas EP. Smith RE, et al. Oncology (Williston Park). 2000 Oct;14(10 Suppl 9):24-7. Oncology (Williston Park). 2000. PMID: 11098486 Clinical Trial.

7

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.

Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C. Meropol NJ, et al. Cancer Invest. 1999;17(1):1-9. Cancer Invest. 1999. PMID: 10999043 Clinical Trial.

8

Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.

Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D; GRECCR Belgium. Focan C, et al. Anticancer Res. 2000 Nov-Dec;20(6C):4665-72. Anticancer Res. 2000. PMID: 11205198 Clinical Trial.

9

A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.

Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH, Chen YC. Yeh KH, et al. Anticancer Res. 1997 Sep-Oct;17(5B):3867-71. Anticancer Res. 1997. PMID: 9427794 Clinical Trial.

10

The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.

Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW. Choi K, et al. Clin Nutr. 2007 Feb;26(1):57-62. doi: 10.1016/j.clnu.2006.07.003. Epub 2006 Sep 1. Clin Nutr. 2007. PMID: 16949180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year